Envestnet Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-134,645
Closed -$13.7M 4749
2025
Q4
$13.7M Sell
134,645
-124,660
-48% -$10M ﹤0.01% 1495
2025
Q3
$14.2M Buy
259,305
+10,770
+4% +$538K ﹤0.01% 1526
2025
Q2
$13.2M Buy
248,535
+2,182
+0.9% +$111K ﹤0.01% 1543
2025
Q1
$10.7M Sell
246,353
-8,891
-3% -$450K ﹤0.01% 1623
2024
Q4
$14.3M Sell
255,244
-44,424
-15% -$2.76M ﹤0.01% 1402
2024
Q3
$20.4M Sell
299,668
-27,242
-8% -$1.54M 0.01% 1175
2024
Q2
$13.8M Sell
326,910
-10,826
-3% -$596K ﹤0.01% 1353
2024
Q1
$23.3M Sell
337,736
-63,594
-16% -$4.02M 0.01% 1020
2023
Q4
$29.7M Buy
401,330
+34,540
+9% +$2.26M 0.01% 834
2023
Q3
$25M Buy
366,790
+42,896
+13% +$3.64M 0.01% 855
2023
Q2
$30.4M Sell
323,894
-4,360
-1% -$340K 0.01% 715
2023
Q1
$22.3M Sell
328,254
-25,570
-7% -$1.64M 0.01% 827
2022
Q4
$17.5M Buy
353,824
+42,712
+14% +$1.75M 0.01% 920
2022
Q3
$10.1M Sell
311,112
-3,063
-1% -$126K 0.01% 1125
2022
Q2
$12.4M Sell
314,175
-8,421
-3% -$450K 0.01% 1036
2022
Q1
$22.6M Sell
322,596
-20,851
-6% -$1.52M 0.01% 795
2021
Q4
$26.7M Buy
343,447
+44,414
+15% +$3.92M 0.01% 723
2021
Q3
$28.5M Buy
299,033
+45,744
+18% +$4.83M 0.02% 651
2021
Q2
$31.5M Buy
253,289
+33,301
+15% +$3.97M 0.02% 615
2021
Q1
$29M Buy
219,988
+57,204
+35% +$7.83M 0.02% 586
2020
Q4
$21.6M Buy
162,784
+32,448
+25% +$3.92M 0.02% 594
2020
Q3
$13.3M Buy
130,336
+94,492
+264% +$8.16M 0.01% 712
2020
Q2
$3.12M Sell
35,844
-2,597
-7% -$207K ﹤0.01% 1355
2020
Q1
$2.23M Sell
38,441
-5,378
-12% -$437K ﹤0.01% 1364
2019
Q4
$4.05M Buy
43,819
+14,152
+48% +$1.24M ﹤0.01% 1246
2019
Q3
$2.68M Buy
29,667
+5,657
+24% +$645K ﹤0.01% 1388
2019
Q2
$2.83M Buy
24,010
+2,361
+11% +$238K ﹤0.01% 1354
2019
Q1
$1.88M Sell
21,649
-1,464
-6% -$125K ﹤0.01% 1519
2018
Q4
$1.46M Buy
23,113
+12,332
+114% +$846K ﹤0.01% 1511
2018
Q3
$851K Buy
10,781
+8,162
+312% +$532K ﹤0.01% 786
2018
Q2
$156K Buy
2,619
+18
+0.7% +$969 ﹤0.01% 1789
2018
Q1
$106K Sell
2,601
-124
-5% -$6.05K ﹤0.01% 1884
2017
Q4
$143K Buy
2,725
+173
+7% +$9.24K ﹤0.01% 1979
2017
Q3
$121K Sell
2,552
-46
-2% -$1.85K ﹤0.01% 2017
2017
Q2
$92K Buy
2,598
+422
+19% +$13K ﹤0.01% 2168
2017
Q1
$52K Buy
2,176
+343
+19% +$6.8K ﹤0.01% 2398
2016
Q4
$25K Sell
1,833
-411
-18% -$6.63K ﹤0.01% 2613
2016
Q3
$42K Buy
2,244
+1,064
+90% +$18.7K ﹤0.01% 2653
2016
Q2
$14K Sell
1,180
-504
-30% -$3.8K ﹤0.01% 3008
2016
Q1
$11K Sell
1,684
-4,361
-72% -$27.9K ﹤0.01% 3032
2015
Q4
$56K Buy
6,045
+2,308
+62% +$21.5K ﹤0.01% 2628
2015
Q3
$67K Buy
+3,737
New +$85.8K ﹤0.01% 2518

Other funds holding EXAS

Envestnet Asset Management's EXAS Position: Q1 2026 in Review

Envestnet Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 134,645 shares — an estimated $13.7M sold.

Envestnet Asset Management first reported a position in EXAS in Q3 2015 and held it in 42 quarters. The position peaked at $31.5M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Envestnet Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 134,645 Exact Sciences shares in Q1 2026, an estimated $13.7M.
  • Envestnet Asset Management first reported a position in Exact Sciences in Q3 2015 and held it in 42 quarters.
  • Envestnet Asset Management's Exact Sciences position peaked at $31.5M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.